Sheharyar Raza Describes the Role of Factor V in Clotting
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared on LinkedIn:
“Clotting relies on coagulation factors, and people lacking them can bleed severely. Yet some factor deficiencies lack replacement agents. Why?
In a new commentary with Jeremy Jacobs and co-authors, we describe the role of Factor V in clotting, its importance for patients with congenital deficiency, gaps in treatment options, and benefits of Factor V repletion for these (and potentially many other) patients
Article ($$) in Seminars in Thrombosis and Hemostasis.”
Title: From Fresh Frozen Plasma to First-in-human: Bringing Coagulation Factor V Deficiency into Therapeutic Trials
Authors: Jeremy W. Jacobs, Sheharyar Raza, Cristina A. Figueroa Villalba, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Deva Sharma, Allison P. Wheeler
Stay informed with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT